1. Impact of PD-L1 Protein Expression on Renal Cell Carcinoma Histo-differentiation.
- Author
-
Tziakou P, Theodoropoulos G, Tsiambas E, Zizi-Sermpetzoglou A, Peschos D, Mastronikoli S, Thomopoulou G, Thymara E, Kavantzas N, and Lazaris AC
- Subjects
- Carcinoma, Renal Cell metabolism, Cell Differentiation, Female, Humans, Kidney Neoplasms metabolism, Male, B7-H1 Antigen metabolism, Biomarkers, Tumor metabolism, Carcinoma, Renal Cell pathology, Kidney Neoplasms pathology
- Abstract
Background/aim: Renal cell carcinoma (RCC) comprises a variety of pathological entities. Many RCCs are aggressive, demanding efficient targeted and immunetherapeutic strategies. Programmed cell death ligand-1 (PD-L1) is expressed mainly in hematopoietic cells and also in epithelial cells. The aim of this study was to correlate PD-L1 protein expression in a series of RCC tissues with their histo-pathological features., Materials and Methods: One hundred (n=100) archival, formalin-fixed and paraffin-embedded RCC tissue specimens were analysed by immunohistochemistry. Conventional tumor proportion score (TPS) qualitative assay was applied for evaluating protein expression levels., Results: Based on the TPS evaluation, 8 (8%) cases were characterized as positive, and the rest of them (n=92; 92%) as negative. A progressive increase in PD-L1 positivity was significantly associated with the differentiation grade of the examined malignancies (p=0.001)., Conclusion: Although PD-L1 over-expression is detected in low rates in RCCs, its correlation with differentiation grade should be considered as a factor for discriminating sub-groups of patients with specific histo-pathological features eligible for targeted anti-PD-L1 immunotherapy strategies., (Copyright © 2021 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF